This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Editorial

. 2002 Jan 10;346(2):126-8.

doi: 10.1056/NEJM200201103460211.

Lung cancer--time to move on from chemotherapy

Desmond N Carney

PMID: 11784881
DOI: 10.1056/NEJM200201103460211

Editorial

Lung cancer--time to move on from chemotherapy

Desmond N Carney. N Engl J Med. 2002.

. 2002 Jan 10;346(2):126-8.

doi: 10.1056/NEJM200201103460211.

Author

Desmond N Carney

PMID: 11784881
DOI: 10.1056/NEJM200201103460211

No abstract available

PubMed Disclaimer

Comment on

Irinotecan plus cisplatin compared with etoposide plus cisplatin for extensive small-cell lung cancer.
Noda K, Nishiwaki Y, Kawahara M, Negoro S, Sugiura T, Yokoyama A, Fukuoka M, Mori K, Watanabe K, Tamura T, Yamamoto S, Saijo N; Japan Clinical Oncology Group. Noda K, et al. N Engl J Med. 2002 Jan 10;346(2):85-91. doi: 10.1056/NEJMoa003034. N Engl J Med. 2002. PMID: 11784874 Clinical Trial.
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer.
Schiller JH, Harrington D, Belani CP, Langer C, Sandler A, Krook J, Zhu J, Johnson DH; Eastern Cooperative Oncology Group. Schiller JH, et al. N Engl J Med. 2002 Jan 10;346(2):92-8. doi: 10.1056/NEJMoa011954. N Engl J Med. 2002. PMID: 11784875 Clinical Trial.

Similar articles

[Irinotecan].
Yokoyama A. Yokoyama A. Nihon Rinsho. 2002 May;60 Suppl 5:339-42. Nihon Rinsho. 2002. PMID: 12101684 Review. Japanese. No abstract available.
Randomized phase III trial of cisplatin/irinotecan versus cisplatin/etoposide in patients with extensive-stage small-cell lung cancer.
Lara PN Jr, Gandara DR, Natale RB. Lara PN Jr, et al. Clin Lung Cancer. 2006 Mar;7(5):353-6. doi: 10.3816/CLC.2006.n.019. Clin Lung Cancer. 2006. PMID: 16640809 Clinical Trial. No abstract available.
[Chemotherapy for small cell lung cancer].
Nakanishi Y, Uchino J. Nakanishi Y, et al. Nihon Kokyuki Gakkai Zasshi. 2004 May;42(5):399-403. Nihon Kokyuki Gakkai Zasshi. 2004. PMID: 15168456 Japanese. No abstract available.
Camptosar plus cisplatin increase survival in small-cell lung cancer study.
[No authors listed] [No authors listed] Oncology (Williston Park). 2000 Sep;14(9):1294. Oncology (Williston Park). 2000. PMID: 11033827 No abstract available.
[Treatment of small cell lung cancer].
Negoro S. Negoro S. Gan To Kagaku Ryoho. 2005 Jun;32(6):777-82. Gan To Kagaku Ryoho. 2005. PMID: 15984515 Review. Japanese.

See all similar articles

Cited by

MLH1 V384D polymorphism associates with poor response to EGFR tyrosine kinase inhibitors in patients with EGFR L858R-positive lung adenocarcinoma.
Chiu CH, Ho HL, Doong H, Yeh YC, Chen MY, Chou TY, Tsai CM. Chiu CH, et al. Oncotarget. 2015 Apr 10;6(10):8407-17. doi: 10.18632/oncotarget.3511. Oncotarget. 2015. PMID: 25823662 Free PMC article.
[Sequential Treatment of Advanced Squamous Lung Cancer:  First-line Gemcitabine +/- platinum Followed by Second-line Taxanes +/- platinum Versus Reverse Sequence].
Xu J, Liu X, Gao H, Guo W, Tang C, Li X, Li J, Qin H, Wang W, Qu L, Wang H, Yang H, Yang L. Xu J, et al. Zhongguo Fei Ai Za Zhi. 2015 May;18(5):308-14. doi: 10.3779/j.issn.1009-3419.2015.05.09. Zhongguo Fei Ai Za Zhi. 2015. PMID: 25975302 Free PMC article. Chinese.
Collagen I promotes epithelial-to-mesenchymal transition in lung cancer cells via transforming growth factor-beta signaling.
Shintani Y, Maeda M, Chaika N, Johnson KR, Wheelock MJ. Shintani Y, et al. Am J Respir Cell Mol Biol. 2008 Jan;38(1):95-104. doi: 10.1165/rcmb.2007-0071OC. Epub 2007 Aug 2. Am J Respir Cell Mol Biol. 2008. PMID: 17673689 Free PMC article.
Brain metastases from solid tumors: disease outcome according to type of treatment and therapeutic resources of the treating center.
Fabi A, Felici A, Metro G, Mirri A, Bria E, Telera S, Moscetti L, Russillo M, Lanzetta G, Mansueto G, Pace A, Maschio M, Vidiri A, Sperduti I, Cognetti F, Carapella CM. Fabi A, et al. J Exp Clin Cancer Res. 2011 Jan 18;30(1):10. doi: 10.1186/1756-9966-30-10. J Exp Clin Cancer Res. 2011. PMID: 21244695 Free PMC article.
High expression of Toll-like receptor 5 correlates with better prognosis in non-small-cell lung cancer: an anti-tumor effect of TLR5 signaling in non-small cell lung cancer.
Zhou H, Chen JH, Hu J, Luo YZ, Li F, Xiao L, Zhong MZ. Zhou H, et al. J Cancer Res Clin Oncol. 2014 Apr;140(4):633-43. doi: 10.1007/s00432-014-1616-4. Epub 2014 Feb 19. J Cancer Res Clin Oncol. 2014. PMID: 24549739 Free PMC article.

See all "Cited by" articles

Publication types

Actions
Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Atypon
- Ovid Technologies, Inc.
Medical
- ClinicalTrials.gov
- MedlinePlus Health Information